AAAAAA

   
Results: 1-4 |
Results: 4
Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil inthe treatment of carcinoma of unknown primary site
Authors: Karapetis, CS Yip, D Virik, K Strickland, A Ryder, K Cowling, M Harper, PG
Citation: Cs. Karapetis et al., Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil inthe treatment of carcinoma of unknown primary site, MED ONCOL, 18(1), 2001, pp. 23-32
Things you learn along the way
Authors: Strickland, A
Citation: A. Strickland, Things you learn along the way, AUST J POL, 35(3), 2000, pp. 534-534
South Australia: Caution and consistency
Authors: Provis, C Strickland, A
Citation: C. Provis et A. Strickland, South Australia: Caution and consistency, AUST J PUBL, 59(4), 2000, pp. 84-92
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel withperipheral blood progenitor cell and filgrastim support for metastatic andlocally advanced breast cancer: Results of a phase I study
Authors: Prince, HM Millward, MJ Rischin, D Blakey, D Francis, P Gates, P Chapple, P Quinn, M Juneja, S Wolf, M Januszewicz, EH Seymour, JF Brettell, M Strickland, A Zalcberg, J Richardson, G Scarlett, J Briggs, P Toner, GC
Citation: Hm. Prince et al., Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel withperipheral blood progenitor cell and filgrastim support for metastatic andlocally advanced breast cancer: Results of a phase I study, ANN ONCOL, 10(4), 1999, pp. 479-481
Risultati: 1-4 |